# Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC

Source: https://onco.cc/trials/nct06864624/  
OnCo record `nct06864624` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of sunvozertinib in lung cancer, run by Tang-Du Hospital, now recruiting.

## Summary

Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC is a phase 2, interventional study registered as NCT06864624 by Tang-Du Hospital, with a registry enrolment figure of 27 participants, started 2025-02-18 and due to reach its primary completion in 2026-12. Interventions recorded: Sunvozertinib. Conditions listed: NSCLC. Primary outcome: Objective response rate (ORR) of neoadjuvant therapy. Lung eligibility wording from the registry: "Non-small cell lung cancer confirmed by histopathology or cytology, clinical stage II, IIIA or IIIB (N2) assessed by the investigator according to AJCC 8th edition". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Also known as: WU-KONG20
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06864624
- Phase: 2
- Setting: Sunvozertinib as Neoadjuvant and Adjuvant Therapy in Stage II-IIIB Non-small-cell Lung Cancer Patients With EGFR Exon 20 Insertion Mutation: a Single-arm, Phase 2 Study (WU-KONG20)
- Sponsor: Tang-Du Hospital
- Enrolled: 27

## Sources

- ClinicalTrials.gov NCT06864624: https://clinicaltrials.gov/study/NCT06864624

## Connected records

- cancers: [EGFR-mutated non-small-cell lung cancer](https://onco.cc/cancers/egfr-mutant-nsclc/), [Resectable stage I to III non-small-cell lung cancer](https://onco.cc/cancers/resectable-nsclc/)
- drugs: [Sunvozertinib](https://onco.cc/drugs/sunvozertinib/)
- companies: [Dizal Pharmaceutical](https://onco.cc/companies/dizal/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06864624.json